Evidence map›Paper›PMID 33033363›Full record

ArticleCommunications biology2020

Caffeine inhibits Notum activity by binding at the catalytic pocket.

Yuguang Zhao, Jingshan Ren, James Hillier, Weixian Lu, Edith Yvonne Jones

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Structural Insights into Notum Covalent Inhibition.Journal of medicinal chemistry · 2021
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuguang ZhaoDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. yuguang@strubi.ox.ac.uk.ORCID http://orcid.org/0000-0001-8916-8552
Jingshan RenDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.ORCID http://orcid.org/0000-0003-4015-1404
James HillierDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Weixian LuDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Edith Yvonne JonesDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK. yvonne@strubi.ox.ac.uk.
Centre for Human Genetics · GB

Funding

Cancer Research UK 17721Cancer Research UK C375/A17721Medical Research Council MR/M000141/1Wellcome TrustWellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

Notum inhibits Wnt signalling via enzymatic delipidation of Wnt ligands. Restoration of Wnt signalling by small molecule inhibition of Notum may be of therapeutic benefit in a number of pathologies including Alzheimer's disease. Here we report Notum activity can be inhibited by caffeine (IC

Indexed as

CaffeineCatalytic DomainDose-Response Relationship, DrugEsterasesHEK293 CellsHumansProtein BindingProtein Structure, TertiaryTheophyllineCaffeineEsterasesNotum protein, humanTheophylline

Identifiers

PMID33033363
PMCPMC7544826
OpenAlexW3092361205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.